Journal article · 2022
Is health-related quality of life (HRQoL) reporting keeping pace with new drug approvals in hematology and oncology: A five-year analysis of 245 drug approvals.
Journal of Clinical Oncology, 40(16_suppl), 6519 · Published 1 June 2022 · DOI 10.1200/jco.2022.40.16_suppl.6519
In brief
“Is health-related quality of life (HRQoL) reporting keeping pace with new drug approvals in hematology and oncology: A five-year analysis of 245 drug approvals.” is a 2022 journal article by Medhavi Gupta and 7 co-authors, published in Journal of Clinical Oncology. OpenAlex counts 1 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 1
- Most cited in
- 2024 (1)
- Authors
- 8
Abstract
6519 Background: HRQoL data in cancer clinical trials can inform tolerability of new drugs, facilitate informed decision-making, and influence health care and policy decisions, but are frequently underreported. We reviewed all registration trials that informed Food and Drug Administration (FDA) approval between 2015-2020 for latency and quality of HRQoL reporting. Methods: HRQoL data for each… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Gupta, M., Akhtar, O. S., Bahl, B., Mier-Hicks, A., Attwood, K. M., Catalfamo, K., Gyawali, B., & Torka, P. (2022). Is health-related quality of life (HRQoL) reporting keeping pace with new drug approvals in hematology and oncology: A five-year analysis of 245 drug approvals. Journal of Clinical Oncology, 40(16_suppl), 6519. https://doi.org/10.1200/jco.2022.40.16_suppl.6519
MLA 9
Gupta, Medhavi, et al. “Is health-related quality of life (HRQoL) reporting keeping pace with new drug approvals in hematology and oncology: A five-year analysis of 245 drug approvals.” Journal of Clinical Oncology, vol. 40, no. 16_suppl, 2022, p. 6519. https://doi.org/10.1200/jco.2022.40.16_suppl.6519.
Chicago
Gupta, Medhavi, Othman Salim Akhtar, Bhavyaa Bahl, Angel Mier-Hicks, Kristopher M. Attwood, Kayla Catalfamo, Bishal Gyawali, and Pallawi Torka. 2022. “Is health-related quality of life (HRQoL) reporting keeping pace with new drug approvals in hematology and oncology: A five-year analysis of 245 drug approvals.” Journal of Clinical Oncology 40 (16_suppl): 6519. https://doi.org/10.1200/jco.2022.40.16_suppl.6519.
Harvard
Gupta, M. et al. (2022) ‘Is health-related quality of life (HRQoL) reporting keeping pace with new drug approvals in hematology and oncology: A five-year analysis of 245 drug approvals.’, Journal of Clinical Oncology, 40(16_suppl), p. 6519. doi:10.1200/jco.2022.40.16_suppl.6519.
IEEE
M. Gupta et al., “Is health-related quality of life (HRQoL) reporting keeping pace with new drug approvals in hematology and oncology: A five-year analysis of 245 drug approvals.,” Journal of Clinical Oncology, vol. 40, no. 16_suppl, p. 6519, 2022, doi: 10.1200/jco.2022.40.16_suppl.6519.
BibTeX
@article{gupta2022health,
title = {{Is health-related quality of life (HRQoL) reporting keeping pace with new drug approvals in hematology and oncology: A five-year analysis of 245 drug approvals.}},
author = {Gupta, Medhavi and Akhtar, Othman Salim and Bahl, Bhavyaa and Mier-Hicks, Angel and Attwood, Kristopher M. and Catalfamo, Kayla and Gyawali, Bishal and Torka, Pallawi},
journal = {Journal of Clinical Oncology},
year = {2022},
volume = {40},
number = {16_suppl},
pages = {6519},
doi = {10.1200/jco.2022.40.16_suppl.6519},
url = {https://doi.org/10.1200/jco.2022.40.16_suppl.6519}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- health-related quality of life
- FDA drug approval
- cancer clinical trials
- hematology
- solid tumors
- clinical trial registration
- time to publication
- overall survival
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Gupta, M., Akhtar, O. S., Bahl, B., Mier-Hicks, A., Attwood, K. M., Catalfamo, K., Gyawali, B., & Torka, P. (2022). Is health-related quality of life (HRQoL) reporting keeping pace with new drug approvals in hematology and oncology: A five-year analysis of 245 drug approvals. Journal of Clinical Oncology, 40(16_suppl), 6519. https://doi.org/10.1200/jco.2022.40.16_suppl.6519
How many times has this paper been cited?
1 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Medhavi Gupta, Othman Salim Akhtar, Bhavyaa Bahl, Angel Mier-Hicks, Kristopher M. Attwood, Kayla Catalfamo, Bishal Gyawali, Pallawi Torka.
What is the DOI of this paper?
10.1200/jco.2022.40.16_suppl.6519, permanently at https://doi.org/10.1200/jco.2022.40.16_suppl.6519. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.